英文别名 |
hVEGF-IN-1;hVEGF inhibitor 1;hVEGF-IN-1, >98%;1-Piperazinepropanamide, N-[2-[4-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-2-quinazolinyl]phenyl]-4-methyl-;N-(2-(4-((4-(2-(diethylamino)ethoxy)phenyl)amino)quinazolin-2-yl)phenyl)-3-(4-methylpiperazin-1-yl)propanamide;BCP32794;CS-7769;HY-101931;1637443-98-1;hVEGF-IN-1?;N-{2-[4-({4-[2-(diethylamino)ethoxy]phenyl}amino)quinazolin-2-yl]phenyl}-3-(4-methylpiperazin-1-yl)propanamide;CHEMBL4082658;N16994;MS-30434;N-[2-[4-[4-[2-(diethylamino)ethoxy]anilino]quinazolin-2-yl]phenyl]-3-(4-methylpiperazin-1-yl)propanamide;AKOS037515563 |